Literature DB >> 26920424

Blood-brain barrier and blood-cerebrospinal fluid barrier in normal and pathological conditions.

Masaki Ueno1, Yoichi Chiba2, Ryuta Murakami2, Koichi Matsumoto2, Machi Kawauchi2, Ryuji Fujihara2.   

Abstract

Blood-borne substances can invade into the extracellular spaces of the brain via endothelial cells in sites without the blood-brain barrier (BBB), and can travel through the interstitial fluid (ISF) of the brain parenchyma adjacent to non-BBB sites. It has been shown that cerebrospinal fluid (CSF) drains directly into the blood via the arachnoid villi and also into lymph nodes via the subarachnoid spaces of the brain, while ISF drains into the cervical lymph nodes through perivascular drainage pathways. In addition, the glymphatic pathway of fluids, characterized by para-arterial pathways, aquaporin4-dependent passage through astroglial cytoplasm, interstitial spaces, and paravenous routes, has been established. Meningeal lymphatic vessels along the superior sagittal sinus were very recently discovered. It is known that, in mice, blood-borne substances can be transferred to areas with intact BBB function, such as the medial regions of the hippocampus, presumably through leaky vessels in non-BBB sites. In the present paper, we review the clearance mechanisms of interstitial substances, such as amyloid-β peptides, as well as summarize models of BBB deterioration in response to different types of insults, including acute ischemia followed by reperfusion, hypertension, and chronic hypoperfusion. Lastly, we discuss the relationship between perivascular clearance and brain disorders.

Entities:  

Keywords:  Blood–brain barrier; Blood–cerebrospinal fluid barrier; Glymphatic pathway; Perivascular drainage pathway

Mesh:

Substances:

Year:  2016        PMID: 26920424     DOI: 10.1007/s10014-016-0255-7

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  35 in total

Review 1.  Human microbiota, blood group antigens, and disease.

Authors:  D Rose Ewald; Susan C J Sumner
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-01-09

2.  Dynamic Contrast-Enhanced MRI Reveals Unique Blood-Brain Barrier Permeability Characteristics in the Hippocampus in the Normal Brain.

Authors:  J Ivanidze; M Mackay; A Hoang; J M Chi; K Cheng; C Aranow; B Volpe; B Diamond; P C Sanelli
Journal:  AJNR Am J Neuroradiol       Date:  2019-02-07       Impact factor: 3.825

Review 3.  The vascular basement membrane in the healthy and pathological brain.

Authors:  Maj S Thomsen; Lisa J Routhe; Torben Moos
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-28       Impact factor: 6.200

Review 4.  Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.

Authors:  Barry Boland; Wai Haung Yu; Olga Corti; Bertrand Mollereau; Alexandre Henriques; Erwan Bezard; Greg M Pastores; David C Rubinsztein; Ralph A Nixon; Michael R Duchen; Giovanna R Mallucci; Guido Kroemer; Beth Levine; Eeva-Liisa Eskelinen; Fanny Mochel; Michael Spedding; Caroline Louis; Olivier R Martin; Mark J Millan
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

5.  Increased Curvature of the Tentorium Cerebelli in Idiopathic Intracranial Hypertension.

Authors:  P P Morris; N Lachman; D F Black; R A Carter; J Port; N Campeau
Journal:  AJNR Am J Neuroradiol       Date:  2017-06-29       Impact factor: 3.825

Review 6.  Binaural blood flow control by astrocytes: listening to synapses and the vasculature.

Authors:  Anusha Mishra
Journal:  J Physiol       Date:  2016-10-14       Impact factor: 5.182

7.  High serum complement component C4 as a unique predictor of unfavorable outcomes in diabetic stroke.

Authors:  Ximeng Zhang; Jun Yin; Kai Shao; Le Yang; Wei Liu; Yiqing Wang; Shanshan Diao; Shicun Huang; Qun Xue; Jianqiang Ni; Yi Yang
Journal:  Metab Brain Dis       Date:  2021-09-04       Impact factor: 3.584

8.  Associations of Pulse and Blood Pressure with Hippocampal Volume by APOE and Cognitive Phenotype: The Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Julius S Ngwa; Thomas V Fungwe; Oyonumo Ntekim; Joanne S Allard; Sheree M Johnson; Chimene Castor; Lennox Graham; Sheeba Nadarajah; Richard F Gillum; Thomas O Obisesan
Journal:  Dement Geriatr Cogn Disord       Date:  2018-04-25       Impact factor: 2.959

9.  Synergistic Development of Biochips and Cell Preservation Methodologies: A Tale of Converging Technologies.

Authors:  Shangping Wang; Gloria D Elliott
Journal:  Curr Stem Cell Rep       Date:  2017-01-21

10.  Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma.

Authors:  Matthias A Karajannis; Audrey Mauguen; Ekrem Maloku; Qingwen Xu; Erin M Dunbar; Scott R Plotkin; Anna Yaffee; Shiyang Wang; J Thomas Roland; Chandranath Sen; Dimitris G Placantonakis; John G Golfinos; Jeffrey C Allen; Nicholas A Vitanza; Luis A Chiriboga; Robert J Schneider; Jingjing Deng; Thomas A Neubert; Judith D Goldberg; David Zagzag; Filippo G Giancotti; Jaishri O Blakeley
Journal:  Mol Cancer Ther       Date:  2021-06-17       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.